正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial evaluating the clinical efficacy of tecovirimat against human clade II mpox. Read the full study for free:

NEJM

1,039,795 subscribers

40,836 次观看 • 5 个月前 •via X (Twitter)

健康养生科学技术

Anya Rossi• Live Now

Private livecam show

1 条评论

Norrification 🇨🇦 的头像

Norrification 🇨🇦5 个月前

@DGlaucomflecken Now THIS is KT! Well done!!

相关视频

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:

Our latest video in our partnership with Dr. Glaucomflecken summarizes a trial assessing the efficacy and safety of intravenous tenecteplase for acute central retinal artery occlusion. Read the full study for free:

NEJM

34,719 次观看 • 5 个月前

Our latest video in our partnership with Dr. Glaucomflecken summarizes the CORALreef Lipids trial, which assessed the efficacy of the oral PCSK9 inhibitor enlicitide in reducing LDL cholesterol levels over a 52-week period. Read the full study for free: #cardiology

Our latest video in our partnership with Dr. Glaucomflecken summarizes the CORALreef Lipids trial, which assessed the efficacy of the oral PCSK9 inhibitor enlicitide in reducing LDL cholesterol levels over a 52-week period. Read the full study for free: #cardiology

NEJM

57,259 次观看 • 6 个月前

Our latest video in partnership with Dr. Glaucomflecken summarizes the ALLEGORY trial that evaluated the efficacy and safety of obinutuzumab when added to standard therapy in adults with active systemic lupus erythematosus. Read the full study for free: #rheumatology

Our latest video in partnership with Dr. Glaucomflecken summarizes the ALLEGORY trial that evaluated the efficacy and safety of obinutuzumab when added to standard therapy in adults with active systemic lupus erythematosus. Read the full study for free: #rheumatology

NEJM

33,417 次观看 • 10 天前

Hey, you should just use a triple pill, Brain Bro. Our latest video in our partnership with Dr. Glaucomflecken summarizes the TRIDENT trial that evaluated the efficacy and safety of a triple-antihypertensive pill after intracerebral hemorrhage. Read the full study for free:

Hey, you should just use a triple pill, Brain Bro. Our latest video in our partnership with Dr. Glaucomflecken summarizes the TRIDENT trial that evaluated the efficacy and safety of a triple-antihypertensive pill after intracerebral hemorrhage. Read the full study for free:

NEJM

37,987 次观看 • 3 个月前

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:

NEJM

19,398 次观看 • 10 个月前

Do the mountains of the Grand Teton range resemble lungs? Our latest video in partnership with Dr. Glaucomflecken summarizes the TETON-2 trial that evaluated the efficacy and safety of inhaled treprostinil in patients with idiopathic pulmonary fibrosis. Read the full study for free: #pulmonology

Do the mountains of the Grand Teton range resemble lungs? Our latest video in partnership with Dr. Glaucomflecken summarizes the TETON-2 trial that evaluated the efficacy and safety of inhaled treprostinil in patients with idiopathic pulmonary fibrosis. Read the full study for free: #pulmonology

NEJM

31,720 次观看 • 24 天前

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:

Our latest video in our partnership with Dr. Glaucomflecken summarizes the POTCAST trial, which assessed a strategy of actively increasing plasma potassium levels to the high-normal range in patients at high risk for ventricular arrhythmias. Read the full study for free:

NEJM

89,851 次观看 • 8 个月前

Our latest video in our partnership with Dr. Glaucomflecken summarizes new research into therapy for atrial fibrillation in patients with drug-eluting stents. Read the full study for free: nej.md/DrG36 #AFib

Our latest video in our partnership with Dr. Glaucomflecken summarizes new research into therapy for atrial fibrillation in patients with drug-eluting stents. Read the full study for free: nej.md/DrG36 #AFib

NEJM

13,414 次观看 • 6 个月前

Dude, Phil, you can’t out-study Infectious Disease. Don’t even try. Our latest video in our partnership with Dr. Glaucomflecken summarizes the AZ-SWED trial that evaluated whether a 5-day course of azithromycin decreases the severity of illness in young children with wheezing. Read the full study for free: #pediatrics

Dude, Phil, you can’t out-study Infectious Disease. Don’t even try. Our latest video in our partnership with Dr. Glaucomflecken summarizes the AZ-SWED trial that evaluated whether a 5-day course of azithromycin decreases the severity of illness in young children with wheezing. Read the full study for free: #pediatrics

NEJM

42,582 次观看 • 2 个月前

Our latest video in our partnership with Dr. Glaucomflecken summarizes the final analysis of 23 years of follow-up to evaluate the long-term effects of PSA screening. Read the full analysis for free:

Our latest video in our partnership with Dr. Glaucomflecken summarizes the final analysis of 23 years of follow-up to evaluate the long-term effects of PSA screening. Read the full analysis for free:

NEJM

185,729 次观看 • 9 个月前

Yes! Journal club! Our latest video in partnership with Dr. Glaucomflecken summarizes the B-Well 1 and B-Well 2 trials investigating bepirovirsen therapy for chronic hepatitis B virus infection. Read the full study for free: #hepatology

Yes! Journal club! Our latest video in partnership with Dr. Glaucomflecken summarizes the B-Well 1 and B-Well 2 trials investigating bepirovirsen therapy for chronic hepatitis B virus infection. Read the full study for free: #hepatology

NEJM

32,725 次观看 • 2 个月前

Phil, this is the kind of question with no clear answers and dozens of opinions that internists dream of! Our latest video in our partnership with Dr. Glaucomflecken summarizes the Ez-PAVE trial that evaluated the appropriate LDL cholesterol target for secondary prevention in patients with atherosclerotic cardiovascular disease. Read the full study for free: #Cardiology

Phil, this is the kind of question with no clear answers and dozens of opinions that internists dream of! Our latest video in our partnership with Dr. Glaucomflecken summarizes the Ez-PAVE trial that evaluated the appropriate LDL cholesterol target for secondary prevention in patients with atherosclerotic cardiovascular disease. Read the full study for free: #Cardiology

NEJM

49,956 次观看 • 4 个月前

Could clesrovimab, a human RSV monoclonal antibody, reduce the incidence of RSV infection in preterm and full-term infants? Find out in the latest video in our partnership with Dr. Glaucomflecken. Read the full results of the CLEVER trial for free:

Could clesrovimab, a human RSV monoclonal antibody, reduce the incidence of RSV infection in preterm and full-term infants? Find out in the latest video in our partnership with Dr. Glaucomflecken. Read the full results of the CLEVER trial for free:

NEJM

46,802 次观看 • 10 个月前

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial that evaluated whether management of shock without early arterial catheterization is noninferior to the practice of early catheter insertion with regard to death from any cause at day 28. Read the full results for free:

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial that evaluated whether management of shock without early arterial catheterization is noninferior to the practice of early catheter insertion with regard to death from any cause at day 28. Read the full results for free:

NEJM

47,914 次观看 • 9 个月前

Which is better? Lactated Ringer’s solution or normal saline? The latest video in our partnership with Dr. Glaucomflecken summarizes the FLUID trial. 👉

Which is better? Lactated Ringer’s solution or normal saline? The latest video in our partnership with Dr. Glaucomflecken summarizes the FLUID trial. 👉

NEJM

87,611 次观看 • 1 年前

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉

For patients with generalized myasthenia gravis, existing treatments reduce mortality and alleviate symptoms, but side effects and poor efficacy leave many patients seeking alternatives. The latest video in our partnership with Dr. Glaucomflecken summarizes the MINT trial. 👉

NEJM

137,433 次观看 • 1 年前

Well, it depends... who do you want to yell at you? Cardiology or Nephrology? Our latest video in partnership with Dr. Glaucomflecken summarizes the ARISE FLUIDS trial that examined whether hemodynamic resuscitation with early vasopressors versus more liberal fluids could affect outcomes in patients with septic shock. Read the full study for free: #emergencymedicine

Well, it depends... who do you want to yell at you? Cardiology or Nephrology? Our latest video in partnership with Dr. Glaucomflecken summarizes the ARISE FLUIDS trial that examined whether hemodynamic resuscitation with early vasopressors versus more liberal fluids could affect outcomes in patients with septic shock. Read the full study for free: #emergencymedicine

NEJM

39,003 次观看 • 1 个月前

In the latest video in our partnership with Dr. Glaucomflecken, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free:

In the latest video in our partnership with Dr. Glaucomflecken, the REGENCY trial investigating the efficacy and safety of obinutuzumab when added to standard therapy in patients with active proliferative lupus nephritis is explained. Access the article for free:

NEJM

144,812 次观看 • 1 年前

Our latest video in our partnership with Dr. Glaucomflecken explores recent research into the safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. Get free access to the article: #IDTwitter

Our latest video in our partnership with Dr. Glaucomflecken explores recent research into the safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. Get free access to the article: #IDTwitter

NEJM

28,105 次观看 • 1 年前

In the latest video in our partnership with Dr. Glaucomflecken, the INSEMA trial investigating axillary surgery in breast cancer is explained. Access the article for free:

In the latest video in our partnership with Dr. Glaucomflecken, the INSEMA trial investigating axillary surgery in breast cancer is explained. Access the article for free:

NEJM

130,645 次观看 • 1 年前